BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33185875)

  • 1. Methods for the Administration of EDAR Pathway Modulators in Mice.
    Schuepbach-Mallepell S; Kowalczyk-Quintas C; Dick A; Eslami M; Vigolo M; Headon DJ; Cheeseman M; Schneider H; Schneider P
    Methods Mol Biol; 2021; 2248():167-183. PubMed ID: 33185875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectodysplasin receptor-mediated signaling is essential for embryonic submandibular salivary gland development.
    Jaskoll T; Zhou YM; Trump G; Melnick M
    Anat Rec A Discov Mol Cell Evol Biol; 2003 Apr; 271(2):322-31. PubMed ID: 12629675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zebrafish eda and edar mutants reveal conserved and ancestral roles of ectodysplasin signaling in vertebrates.
    Harris MP; Rohner N; Schwarz H; Perathoner S; Konstantinidis P; Nüsslein-Volhard C
    PLoS Genet; 2008 Oct; 4(10):e1000206. PubMed ID: 18833299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Mutations of the Three Ectodysplasin Pathway Key Players (
    Ahmed HA; El-Kamah GY; Rabie E; Mostafa MI; Abouzaid MR; Hassib NF; Mehrez MI; Abdel-Kader MA; Mohsen YH; Zada SK; Amr KS; Sayed ISM
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological stimulation of Edar signaling in the adult enhances sebaceous gland size and function.
    Kowalczyk-Quintas C; Schuepbach-Mallepell S; Willen L; Smith TK; Huttner K; Kirby N; Headon DJ; Schneider P
    J Invest Dermatol; 2015 Feb; 135(2):359-368. PubMed ID: 25207818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into pathogenic mechanism of hypohidrotic ectodermal dysplasia caused by ectodysplasin A variants.
    Yu K; Huang C; Wan F; Jiang C; Chen J; Li X; Wang F; Wu J; Lei M; Wu Y
    Nat Commun; 2023 Feb; 14(1):767. PubMed ID: 36765055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectodysplasin A (EDA) - EDA receptor signalling and its pharmacological modulation.
    Kowalczyk-Quintas C; Schneider P
    Cytokine Growth Factor Rev; 2014 Apr; 25(2):195-203. PubMed ID: 24508088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular aspects of hypohidrotic ectodermal dysplasia.
    Mikkola ML
    Am J Med Genet A; 2009 Sep; 149A(9):2031-6. PubMed ID: 19681132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turkish Ectodermal Dysplasia Cohort: From Phenotype to Genotype in 17 Families.
    Güven Y; Bal E; Altunoglu U; Yücel E; Hadj-Rabia S; Koruyucu M; Bahar Tuna E; Çıldır Ş; Aktören O; Bodemer C; Uyguner ZO; Smahi A; Kayserili H
    Cytogenet Genome Res; 2019; 157(4):189-196. PubMed ID: 30974434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EDA, EDAR, EDARADD and WNT10A allelic variants in patients with ectodermal derivative impairment in the Spanish population.
    Martínez-Romero MC; Ballesta-Martínez MJ; López-González V; Sánchez-Soler MJ; Serrano-Antón AT; Barreda-Sánchez M; Rodriguez-Peña L; Martínez-Menchon MT; Frías-Iniesta J; Sánchez-Pedreño P; Carbonell-Meseguer P; Glover-López G; Guillén-Navarro E;
    Orphanet J Rare Dis; 2019 Dec; 14(1):281. PubMed ID: 31796081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Edar and Troy signalling pathways act redundantly to regulate initiation of hair follicle development.
    Pispa J; Pummila M; Barker PA; Thesleff I; Mikkola ML
    Hum Mol Genet; 2008 Nov; 17(21):3380-91. PubMed ID: 18689798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Only four genes (EDA1, EDAR, EDARADD, and WNT10A) account for 90% of hypohidrotic/anhidrotic ectodermal dysplasia cases.
    Cluzeau C; Hadj-Rabia S; Jambou M; Mansour S; Guigue P; Masmoudi S; Bal E; Chassaing N; Vincent MC; Viot G; Clauss F; Manière MC; Toupenay S; Le Merrer M; Lyonnet S; Cormier-Daire V; Amiel J; Faivre L; de Prost Y; Munnich A; Bonnefont JP; Bodemer C; Smahi A
    Hum Mutat; 2011 Jan; 32(1):70-2. PubMed ID: 20979233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of dkk4 as a target of Eda-A1/Edar pathway reveals an unexpected role of ectodysplasin as inhibitor of Wnt signalling in ectodermal placodes.
    Fliniaux I; Mikkola ML; Lefebvre S; Thesleff I
    Dev Biol; 2008 Aug; 320(1):60-71. PubMed ID: 18508042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel death domain-containing adaptor molecule for ectodysplasin-A receptor that is mutated in crinkled mice.
    Yan M; Zhang Z; Brady JR; Schilbach S; Fairbrother WJ; Dixit VM
    Curr Biol; 2002 Mar; 12(5):409-13. PubMed ID: 11882293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectodysplasin A Pathway Contributes to Human and Murine Skin Repair.
    Garcin CL; Huttner KM; Kirby N; Schneider P; Hardman MJ
    J Invest Dermatol; 2016 May; 136(5):1022-1030. PubMed ID: 26829034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectodysplasin signalling deficiency in mouse models of hypohidrotic ectodermal dysplasia leads to middle ear and nasal pathology.
    Azar A; Piccinelli C; Brown H; Headon D; Cheeseman M
    Hum Mol Genet; 2016 Aug; 25(16):3564-3577. PubMed ID: 27378689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ectodysplasin signalling in middle ear and nasal pathology in rat and mouse models of hypohidrotic ectodermal dysplasia.
    Del-Pozo J; MacIntyre N; Azar A; Headon D; Schneider P; Cheeseman M
    Dis Model Mech; 2019 Apr; 12(4):. PubMed ID: 31028034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and therapeutic characterization of anti-ectodysplasin A receptor (EDAR) agonist monoclonal antibodies.
    Kowalczyk C; Dunkel N; Willen L; Casal ML; Mauldin EA; Gaide O; Tardivel A; Badic G; Etter AL; Favre M; Jefferson DM; Headon DJ; Demotz S; Schneider P
    J Biol Chem; 2011 Sep; 286(35):30769-30779. PubMed ID: 21730053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene defect in ectodermal dysplasia implicates a death domain adapter in development.
    Headon DJ; Emmal SA; Ferguson BM; Tucker AS; Justice MJ; Sharpe PT; Zonana J; Overbeek PA
    Nature; 2001 Dec 20-27; 414(6866):913-6. PubMed ID: 11780064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia.
    Schneider H; Hadj-Rabia S; Faschingbauer F; Bodemer C; Grange DK; Norton ME; Cavalli R; Tadini G; Stepan H; Clarke A; Guillén-Navarro E; Maier-Wohlfart S; Bouroubi A; Porte F
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.